Hemodynamic monitoring, preload, non-invasive monitoring, pulse wave transit time, stroke volume.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: voluntary participation, written informed consent.
Exclusion criteria
Exclusion criteria: Cardiovascular diseases (in particular cardiac valve disease, hypotension or taking of any cardiovascular drugs), acute illness within 7 days prior to measurements, expected difficulties in TTE-measurements (e.g. adipositas per magna), peripheral vasoconstriction due to hypothermia, drugs or Raynaud syndrome, pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in PWTT measurements 1 minute and 5 minutes after completion of each physical task as well as after return to baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in hemodynamic parameters stroke volume (SV), heart frequency (HF) and mean arterial pressure (MAP) 1 minute and 5 minutes after completion of each physical task as well as after return to baseline. | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie, Universitätsmedizin Mainz